In conclusion our studies provide a comprehensive view on the expression of miRNAs in neuroblastoma and provide further insights into the pro-oncogenic role of the RNA-binding protein IGF2BP1 involving positive feed-back regulation with MYCN in neuroblastoma, in particular MYCN-amplified (MNA) diseases. This evidence concerns the gene MYCN and neuroblastoma.